Global Pneumonia Vaccine Market to Reach $12.67B by 2034, Driven by Expanded Immunization & Next-Gen Vaccines Global Pneumonia Vaccine Market to Reach $12.67B by 2034, Driven by Expanded Immunization & Next-Gen Vaccines Pneumonia vaccines help protect against serious infections caused by Streptococcus pneumoniae, including pneumonia, meningitis, and sepsis. The two main types are Pneumococcal Conjugate Vaccines (PCV) and Pneumococcal Polysaccharide Vaccines (PPSV), widely used for children and older adults. Market growth is driven by: Expanding global immunization programs Rising elderly population Development of advanced vaccines like PCV15 and PCV20 Leading companies such as Pfizer Inc., GlaxoSmithKline plc, and Merck & Co., Inc. continue to invest in next-generation vaccines. North America leads the market, while Asia-Pacific is the fastest-growing region due to improving healthcare access. https://www.intelmarketresearch.com/download-free-sample/34443/pneumonia-vaccine-market